Zerion Pharma A/S: Financial statements 2022
CVR: 40169229
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Zerion Pharma A/S (CVR 40169229) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 3,273,327 and a net result of DKK -18,857,318 compared with DKK -11,134,049 the year before. That is an increase of 69.4% compared with the year before. The profit margin was -576.1%. Equity in the 2022 report amounted to DKK -9,958,078. The company had 12 employees in the financial year.
- Revenue
- DKK 3,273,327
- Gross Profit
- DKK -10,912,651
- Profit/Loss
- DKK -18,857,318
- Equity
- DKK -9,958,078
- Total Assets
- DKK 12,423,255
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 3.3 mio. | -10.9 mio. | -18.9 mio. | -10 mio. | 12 |
| 2021 | 1.9 mio. | -6.7 mio. | -11.1 mio. | -867 t. | 8 |
| 2020 | - | 784 t. | -3.5 mio. | -1 mio. | 3 |
| 2019 | - | -1.1 mio. | -1.1 mio. | 31 t. | 3 |
Official annual report
Keep an eye on Zerion Pharma A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Zerion Pharma A/S has published its annual report for 2021. Revenue came to DKK 1,932,775, and the net result was DKK -11,134,049.
About Zerion Pharma A/S
Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The board consists of Carl-Åke Carlsson (chair), Geelanie Rodriguez Briones, Allan Stich and Dorte Juhl Arnbjerg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. The company has 15 employees (2026). In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity in the 2025 report amounted to DKK -3,511,410.